Skip to content
Tenfell
Closed tender
Published 30 Apr 2021

NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East

NHS England · London

Key facts

Estimated value
£441,994,547
Closing date
04 Jun 2021
Contract starts
31 Aug 2021
Contract ends
31 Aug 2023
Procedure
Open procedure (above threshold)
Buyer type
Central government

Description

Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months. Lot 03 - SOUTH of England Tranche A. Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 months Lot 04- SOUTH of England - Tranche B. Period of framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 05 - SOUTH of England Annual Tranche. Period of Framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 06 - Mids & East and North of England Regions - Bevacizumab. Period of Framework: 01/09/21 - 28/02/22 with option to extend for a period of 6 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.